Covid-19 Vaccine Generates Antibodies and T-Cells in Phase I Trial

biospace.com

2 pointslowmemcpu2 comments

This is promising news, nothing for certain, but promising. Thanks for sharing.

The Full title did not fit, so I did my best to make it fit. Here it is:

"Report: AstraZeneca's COVID-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phase I Trial"